Item 7.01 Regulation FD Disclosure

On January 11, 2023, Lantheus Holdings, Inc. (the "Company") is delivering a presentation at the 41st Annual J.P. Morgan Healthcare Conference, which also will be webcast live. A copy of the slide presentation that will be used by representatives of the Company in connection with the presentation (the "Corporate Presentation") is attached to this Current Report on Form 8-K as Exhibit 99.1. The Corporate Presentation is current as of January 11, 2023, and the Company disclaims any obligation to update or revise the Corporate Presentation, including with respect to any forward-looking statements, to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required by law.

The information in this Item 7.01 and Exhibit 99.1 attached hereto are intended to be furnished and shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



Exhibit
Number       Exhibit Description

99.1*          Corporate Presentation

104          Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed"

for purposes of Section 18 of the Exchange Act or otherwise subject to the

liabilities of that section, nor shall such information be deemed incorporated

by reference in any filing under the Securities Act of 1933, as amended, except

as shall be expressly set forth by specific reference in such filing.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses